The association between systemic inflammatory response index and in-hospital mortality in patients with infective endocarditis
- PMID: 35403723
- PMCID: PMC9175252
- DOI: 10.1002/clc.23829
The association between systemic inflammatory response index and in-hospital mortality in patients with infective endocarditis
Abstract
Background: Infective endocarditis (IE) has a significant mortality, and early identification of high-risk patients and prediction of poor outcomes is of great significance. In recent years, increasing research has revealed the predictors associated with infective endocarditis prognosis. Systemic inflammatory response index (SIRI) is an important new indicator of inflammation. So far, there have been no reports on the relationship between SIRI and the prognosis of IE patients.
Hypothesis: The purpose of this study was to explore the value of SIRI in predicting in-hospital death for patients with infective endocarditis (IE), so as to provide reference for improving the prognosis of patients with IE.
Method: A retrospective analysis was performed on the clinical data of patients with IE admitted to the First Affiliated Hospital of Nanjing Medical University from January 2017 to December 2019. SIRI was calculated according to the blood routine results of patients at admission; receiver operating characteristic curve was employed to determined the optimal cutoff value of SIRI. Patients were divided into groups (low SIRI group and high SIRI group; nonsurvivor group and survivor group) according to the levels of SIRI or their prognosis, and the general clinical features of the two groups were compared. Univariate and multivariate logistic regression analysis were performed to analyze the independent prognostic factors of in-hospital death in IE patients.
Results: A total of 147 IE patients meeting the diagnostic criteria were included, including 102 males (69.4%) and 45 females (30.6%). There was statistically significant difference in SIRI level between nonsurvivor group and survivor group (p < .05). After adjusting for the related factors, the risk of in-hospital death in the high SIRI was still a risk of in-hospital death with statistical significance (hazard ratio = 5.053, 95% confidence interval: 1.426-17.905, p = .012).
Conclusions: Higher SIRI level is independently associated with the risk of in-hospital death in IE patients, and can be an independent predictor of poor outcome in IE patients.
Keywords: SIRI; infective endocarditis; prognosis.
© 2022 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Prognostic Value of Lymphocyte-to-White Blood Cell Ratio for In-Hospital Mortality in Infective Endocarditis Patients.Int J Clin Pract. 2022 Feb 25;2022:8667054. doi: 10.1155/2022/8667054. eCollection 2022. Int J Clin Pract. 2022. PMID: 35685545 Free PMC article.
-
A New Clinical Prediction Rule for Infective Endocarditis in Emergency Department Patients With Fever: Definition and First Validation of the CREED Score.J Am Heart Assoc. 2023 May 2;12(9):e027650. doi: 10.1161/JAHA.122.027650. Epub 2023 Apr 29. J Am Heart Assoc. 2023. PMID: 37119081 Free PMC article.
-
Multivariate and survival analysis of prognosis and surgical benefits in infective endocarditis.Scand Cardiovasc J. 2025 Dec;59(1):2429994. doi: 10.1080/14017431.2024.2429994. Epub 2024 Dec 24. Scand Cardiovasc J. 2025. PMID: 39718350
-
Cardiac troponin and infective endocarditis prognosis: a systematic review and meta-analysis.Eur Heart J Acute Cardiovasc Care. 2021 May 11;10(3):356-366. doi: 10.1093/ehjacc/zuab008. Eur Heart J Acute Cardiovasc Care. 2021. PMID: 33668065
-
Incidence and mortality of infective endocarditis in the last decade: a single center study.J Cardiovasc Med (Hagerstown). 2023 Feb 1;24(2):105-112. doi: 10.2459/JCM.0000000000001410. Epub 2022 Dec 22. J Cardiovasc Med (Hagerstown). 2023. PMID: 36574285 Review.
Cited by
-
The systemic inflammatory response index is associated with chronic kidney disease in patients with hypertension: data from the national health and nutrition examination study 1999-2018.Ren Fail. 2024 Dec;46(2):2396459. doi: 10.1080/0886022X.2024.2396459. Epub 2024 Sep 23. Ren Fail. 2024. PMID: 39311633 Free PMC article.
-
The Prognostic Value of Hematologic Inflammatory Markers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221146183. doi: 10.1177/10760296221146183. Clin Appl Thromb Hemost. 2022. PMID: 36567485 Free PMC article.
-
Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)-The Prognosis Lies in the Blood.Biomedicines. 2025 Jul 14;13(7):1719. doi: 10.3390/biomedicines13071719. Biomedicines. 2025. PMID: 40722789 Free PMC article.
-
Determining Diagnostic Sensitivity: A Comparison of Rose Bengal Test, Coombs Gel Test, ELISA and Bacterial Culture in Brucellosis Diagnosis-Analyzing Clinical Effectiveness in Light of Inflammatory Markers.Diagnostics (Basel). 2024 Jul 17;14(14):1546. doi: 10.3390/diagnostics14141546. Diagnostics (Basel). 2024. PMID: 39061683 Free PMC article.
-
Systemic inflammation response index as a prognostic factor for patients with sepsis-associated acute kidney injury: a retrospective observational study.J Int Med Res. 2024 Mar;52(3):3000605241235758. doi: 10.1177/03000605241235758. J Int Med Res. 2024. PMID: 38518195 Free PMC article.
References
-
- Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379(9819):965‐975. - PubMed
-
- Hubert S, Thuny F, Resseguier N, et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol. 2013;62(15):1384‐1392. - PubMed
-
- Yu CW, Juan LI, Hsu SC, et al. Role of procalcitonin in the diagnosis of infective endocarditis: a meta‐analysis. Am J Emerg Med. 2013;31(6):935‐941. - PubMed
-
- Qi Q, Zhuang L, Shen Y, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer‐Am Cancer Soc. 2016;122(14):2158‐2167. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical